Daniel Antier
Impact in
-
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Analytical Methods in Pharmaceuticals 7
-
- Neuroinflammation and Neurodegeneration Mechanisms 5
- Co-authors
- Gaël Y. Rochefort (10 shared papers)Sylvie Chalon (7 shared papers)Sylvie Bodard (5 shared papers)Véronique Eder (9 shared papers)Claire Tronel (4 shared papers)Nicolas Arlicot (5 shared papers)Jean-Marc Hyvelin (6 shared papers)Guylène Page (2 shared papers)
- Journals
- Journal of Pharmaceutical and Biomedical Analysis (2 papers)European Journal of Pharmacology (2 papers)International Journal of Clinical Pharmacy (2 papers)Cardiovascular Toxicology (1 paper)Medicine & Science in Sports & Exercise (1 paper)
- Partner nations
- FranceSwitzerlandUnited Kingdom
In The Last Decade
Daniel Antier
44 papers receiving 529 citations
Peers
Comparison fields: 5 of 75
- Biological Psychiatry 10
- Neurology 43
- Geriatrics and Gerontology 13
- Aging 5
- Applied Microbiology and Biotechnology 7
Countries citing papers authored by Daniel Antier
This map shows the geographic impact of Daniel Antier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Antier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Antier more than expected).
Fields of papers citing papers by Daniel Antier
This network shows the impact of papers produced by Daniel Antier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Antier. The network helps show where Daniel Antier may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Antier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 48 | |
| 2 | 2013 | 45 | |
| 3 | 2013 | 41 | |
| 4 | 2017 | 32 | |
| 5 | 2017 | 29 | |
| 6 | 2007 | 27 | |
| 7 | 2007 | 24 | |
| 8 | 2009 | 17 | |
| 9 | 2014 | 17 | |
| 10 | 2018 | 17 | |
| 11 | 2007 | 15 | |
| 12 | 2018 | 15 | |
| 13 | 2006 | 14 | |
| 14 | 2011 | 14 | |
| 15 | 2009 | 13 | |
| 16 | 2021 | 13 | |
| 17 | 2003 | 12 | |
| 18 | 2006 | 12 | |
| 19 | 2006 | 12 | |
| 20 | 2014 | 11 |
About Daniel Antier
Daniel Antier is a scholar working on Analytical Chemistry, Neurology, Pulmonary and Respiratory Medicine, Occupational Therapy and Molecular Biology, having authored 46 papers that have together received 548 indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (7 papers), Heme Oxygenase-1 and Carbon Monoxide (6 papers), Pulmonary Hypertension Research and Treatments (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Nicotinic Acetylcholine Receptors Study (3 papers), Safe Handling of Antineoplastic Drugs (3 papers) and Blood properties and coagulation (3 papers). The work is most often cited by research in Biological Psychiatry (10 citations), Neurology (43 citations), Geriatrics and Gerontology (13 citations), Aging (5 citations) and Applied Microbiology and Biotechnology (7 citations). Daniel Antier has collaborated with scholars based in France, Switzerland and United Kingdom. Frequent co-authors include Gaël Y. Rochefort, Sylvie Chalon, Sylvie Bodard, Véronique Eder, Claire Tronel, Nicolas Arlicot, Jean-Marc Hyvelin, Guylène Page, Marie‐Christine Machet and Fabien Lamoureux. Their work appears in journals such as Journal of Pharmaceutical and Biomedical Analysis, European Journal of Pharmacology, International Journal of Clinical Pharmacy, Cardiovascular Toxicology and Medicine & Science in Sports & Exercise.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.